Page 102 - JCBP-3-2
P. 102

Journal of Clinical and
            Basic Psychosomatics                                                    Menstrual psychosis and treatment




            Table 1. Classification by timing within menstrual cycle 1  conclusion regarding hormone levels, symptoms, and
                                                               treatment response cannot be made for this patient,
            Classification             Description             inferences can be made given the time course of symptoms
            Premenstrual    Starts during the second half of the cycle, and   and response to contraceptive medication. Further research
            psychosis       sometimes end with abrupt recovery at the
                            onset of menstrual bleeding        is needed to determine the role of menstrual cycles in
            Catamenial psychosis  Begins with the onset of menstrual flow  mental health disorders and to identify effective treatment
                                                               options for these conditions. Documenting pre-  and
            Para-menstrual   Psychoses with variable timing, always in   post-treatment hormonal levels may provide valuable
            psychosis       harmony with the menstrual cycle
            Mid-cycle psychosis  The onset is mid-way of menstrual bleeding   information into the etiology of menstrual psychosis as
                                                               well as treatment response.
            Epochal menstrual   Bipolar psychoses lasting for the complete
            psychosis       cycle, with switches linked to menstruation
                                                               4. Conclusion
                                                               Menstrual  psychosis  is  a  rare  and  self-limiting  illness
            controversy, these researchers agree that antipsychotic   characterized  by  the  acute  onset  of  psychotic  symptoms
            treatment is usually ineffective and that steroid hormones
            and clomiphene are better treatment options. While case   during certain stages of the menstrual cycle. The
            reports alone cannot guide treatment or policy, they offer   relationship between psychosis and the menstrual cycle
                                                               is not easy for clinicians to recognize, especially at the
            valuable learning resources for science and suggest areas
            for future research. 11                            first presentation. This case report describes a 40-year-
                                                               old female who presented to the inpatient psychiatric
              Treatment for psychosis related to menstruation   unit with psychotic symptoms including delusions,
            typically involves antipsychotics, but some evidence   paranoia, disorganized thought process, and agitation
            suggests combining antipsychotics with contraceptives   coinciding with the premenstrual phase of her period.
                                                  3
            may be effective for treatment and prevention.  In a case   She  was  stabilized  on  a  regimen  of  olanzapine  and  a
            series by Ray and Paul,  a 14-year-old girl with a diagnosis   medroxyprogesterone  hormonal  contraceptive  injection.
                              12
            of possible menstrual psychosis was initially treated with   The patient also had a history of sexual abuse that may
            olanzapine (continued at 10 mg/day) and then prescribed   have impacted her symptoms. Medical records showed no
            oral contraceptive pills containing norethindrone/ethinyl   recrudescence of psychotic symptoms and no subsequent
            estradiol. She was eventually tapered off olanzapine and   psychiatric hospitalizations throughout the follow-up
            remained stable on only the oral contraceptive. Our case   period. Research on menstrual-related psychosis remains
            supports the use of contraceptives in patients experiencing   limited, and this case adds valuable data to the developing
            menstrual psychosis.                               body of knowledge in this area.
              This case highlights the importance of considering
            menstrual cycles in mental health disorders. The patient   Acknowledgments
            reported a worsening of symptoms in the week before her   None.
            period, which  aligns  with a possible menstrual-related
            component. The patient’s symptoms were consistent with   Funding
            unspecified psychosis and raised suspicion for substance-  None.
            induced psychosis, mood disorder with psychotic features,
            and organic psychotic disorder. Her use of cannabinoids   Conflict of interest
            and methylphenidate may have contributed to worsening
            symptoms, possibly explaining why this was the first   The authors declare no competing of interest.
            hospitalization. Olanzapine does not appear to have
            prevented relapse of psychotic symptoms during the next   Author contributions
            period, consistent with other case reports indicating that   Conceptualization: John C. Garman
            olanzapine does not completely resolve cases of menstrual   Investigation: All authors
            psychosis. 13,14   However,  her  continued  improvement   Writing–original draft: John C. Garman
            with olanzapine and contraceptive use may suggest an   Writing–review & editing: All authors
            effective treatment combination for patients suffering from
            menstruation-related psychosis.                    Ethics approval and consent to participate
              A limitation of this study is that we did not have   Patient gave written consent before her participation after
            pre- and post-treatment hormone levels. While a definitive   her psychotic condition improved.


            Volume 3 Issue 2 (2025)                         96                              doi: 10.36922/jcbp.4721
   97   98   99   100   101   102   103   104   105   106   107